In Brief: Bio-Technology General's BioLon
This article was originally published in The Gray Sheet
Executive Summary
Bio-Technology General's BioLon: Firm receives FDA approvable letter Feb. 3 for the 1% sodium hyaluronate viscoelastic lubricant for use in ophthalmic procedures such as cataract removal. The Iselin, New Jersey company says final approval is expected following FDA inspection of the contracted final sterilizer for the product and submission of final labeling...